GS
Gilead Sciences Inc
🇩🇪XETR.GISGermanyHealthcare
€128.68EURup +2.44 (+1.93%)ClosedEnd of day6:28 PM
Price€128.68+2.44 (+1.93%)
Profile
- Healthcare
- Drug Manufacturers - General
- Germany
Identity
- Exchange
- Xetra . XETR
- Type
- Stock
- ISIN
- US3755581036
- CUSIP
- Not reported
Company
- Employees
- 17,000
- Headquarters
- Foster City, United States
- Website
- https://www.gilead.com
- CEO
- Mr. Daniel Patrick O'Day
Market
- Shares outstanding
- 1.2B
- Market cap
- €159.77B
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- €156.74B
- EPS LTM
- -$2.61
- P/E LTM
- -48.47
- Div yield
- 2.59%
Fundamentals (LTM)
- Revenue
- $30.46B+5.52%up year on year
- Net income
- -$3.24B-151.34%down year on year
- Gross margin
- 79.59%+1.34%up year on year
- Free cash flow
- $13.2B+40.88%up year on year
Other listings
- XSTU.GISStuttgart Stock Exchange
- XMEX.GILDMexican Stock Exchange
- XFRA.GISFrankfurt Stock Exchange
- BVMF.GILD34B3 - Brasil Bolsa Balcão
- XNAS.GILDNasdaq
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.